Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: New Jersey 19 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PHASE4INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of a Weight Loss Intervention in People With Endometrial Cancer
EARLY_PHASE1INTERVENTIONAL Basking Ridge, New Jersey +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Metabolic Health, Bones and Nuts During Weight Loss in Adults
NAINTERVENTIONAL New Brunswick, New Jersey
RECRUITING
Extracellular Vesicles, Insulin Action, and Exercise
NAINTERVENTIONAL New Brunswick, New Jersey +2 more
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
NAINTERVENTIONAL Brooklyn, New York
RECRUITING
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
N/AOBSERVATIONAL Brooklyn, New York
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
N/AOBSERVATIONAL Brooklyn, New York
RECRUITING
Filter Trials
Trial Phase
Study Type